University of Pennsylvania

ScholarlyCommons
Departmental Papers (BE)

Department of Bioengineering

8-17-2003

Mechanisms of central sensitization, neuroimmunology and injury
biomechanics in persistent pain : implications for
musculoskeletal disorders
Beth A. Winkelstein
University of Pennsylvania, winkelst@seas.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/be_papers
Part of the Biomechanics and Biotransport Commons

Recommended Citation
Winkelstein, B. A. (2003). Mechanisms of central sensitization, neuroimmunology and injury
biomechanics in persistent pain : implications for musculoskeletal disorders. Retrieved from
https://repository.upenn.edu/be_papers/2

Postprint version. Published in Journal of Electromyography and Kinesiology, Volume 14, Issue 1, February 2004,
pages 87-93.
Publisher URL: http://dx.doi.org/10.1016/j.jelekin.2003.09.017
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/be_papers/2
For more information, please contact repository@pobox.upenn.edu.

Mechanisms of central sensitization, neuroimmunology and injury biomechanics
in persistent pain : implications for musculoskeletal disorders
Abstract
This review will offer an overview of the mechanistic pathways of chronic pain associated with
musculoskeletal disorders (MSDs). Traditional electrophysiological pain pathways of these injuries will be
reviewed. In addition, recent research efforts in persistent pain have characterized a cascade of
neuroimmunologic events in the central nervous system that manifests in pain behaviors and
neurochemical nociceptive responses. Physiologic changes in the central nervous system will be covered
as they pertain to the interplay of these two areas, and also as they focus on MSDs and injuries. One such
injury leading to persistent pain is radiculopathy, which results from nerve root compression or
impingement and leads to low back pain. This painful syndrome will be used as an example to provide a
context for presenting immune mechanisms of chronic pain and their relationship to injury. Measures of
injury biomechanics are presented in the context of the resulting pain responses, including behavioral
sensitivity, local structural changes, and cellular and molecular changes in the CNS. Lastly, based on
these findings and others, a discussion is provided highlighting areas of future work to help elucidate
methods of injury diagnosis and development of therapeutic treatments.
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ABSTRACT
This review will offer an overview of the mechanistic pathways of chronic pain associated with
musculoskeletal disorders (MSDs).
injuries will be reviewed.

Traditional electrophysiological pain pathways of these

In addition, recent research efforts in persistent pain have

characterized a cascade of neuroimmunologic events in the central nervous system that manifests
in pain behaviors and neurochemical nociceptive responses. Physiologic changes in the central
nervous system will be covered as they pertain to the interplay of these two areas, and also as
they focus on MSDs and injuries. One such injury leading to persistent pain is radiculopathy,
which results from nerve root compression or impingement and leads to low back pain. This
painful syndrome will be used as an example to provide a context for presenting immune
mechanisms of chronic pain and their relationship to injury. Measures of injury biomechanics
are presented in the context of the resulting pain responses, including behavioral sensitivity, local
structural changes, and cellular and molecular changes in the CNS. Lastly, based on these
findings and others, a discussion is provided highlighting areas of future work to help elucidate
methods of injury diagnosis and development of therapeutic treatments.
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Painful musculoskeletal disorders (MSDs) are a common problem in today’s society,
affecting an estimated one-third of the population. The societal costs, including litigation, worklost, treatment and disability, for painful MSDs are staggering. For example, the cost of low back
pain alone has been estimated to be between 40-50 billion dollars annually [20,21]. Until we gain a
better understanding of the pathomechanisms in chronic pain and the injuries which cause them
their effective prevention and treatment will remain somewhat elusive. It is the intent of this review
to highlight traditional and emerging theories of pain transmission in the context of injury and
MSDs. A brief discussion of the neurophysiology of pain highlights traditional concepts of injury
and pain processing and more recent hypotheses of the central nervous system’s (CNS)
neuroimmunologic involvement in persistent pain. This discussion is followed by a presentation of
biomechanical considerations for painful injuries and MSDs.

Incorporating effects of injury

parameters on mechanisms of persistent pain, text discusses implication of all of these for MSD.
Lastly, a discussion of clinical implications of these findings and suggested areas of future work is
offered. It is important to define, at the outset, relevant distinctions in terminology. “Pain” is a
complex perception that is influenced by prior experience and by the context within which the
noxious stimulus occurs; “nociception” is the physiologic response to tissue damage or prior tissue
damage.

MECHANISMS OF PAIN: NEUROPHYSIOLOGY & NEUROIMMUNOLOGY
There are a host of physiologic mechanisms by which injuries lead to nociceptive responses,
and ultimately pain. In persistent pain, CNS signals can result in a hypersensitivity or central
sensitization response. In addition to the electrophysiologic changes leading to central sensitization,
the CNS mounts a series of neuroimmune responses which may further contribute to sensitization
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and persistent pain symptoms. The findings with regard to neuroimmunity are reviewed here to
form a basis for discussing more recent views of persistent pain mechanisms.
Tissue Injury, Central Sensitization & Pain
Injury to a broad number of tissue components, including muscle, disc, and ligament,
produces a variety of signals leading to pain perception. Neuroplasticity and subsequent CNS
sensitization include altered function of chemical, electrophysiological, and pharmacological
systems [3,13,15,41,44,50]. These are complicated and intricately involved with injury and changes
in both the peripheral and central nervous systems (Figure 1).
An initial insult (injury- or inflammation-induced) activates local nociceptors (Figure 1).
These A and C pain nerve fibers in turn become sensitized and have both lower thresholds for
firing and increased firing rates when stimulated at levels similar to before injury [4]. In addition to
altered electrical responses, injury initiates the synthesis and release of inflammatory mediators that
act to induce inflammation and edema as part of the healing process. However, these healing
activities also sensitize nociceptors and recruit new nociceptors to enhance pain [17,19]. Such
chemical mediators include, but are not limited to, excitatory amino acids, nitric oxide, bradykinin,
prostaglandins, histamine, and substance P [4,26]. Cytokines are also released in the periphery in
association with tissue injury and inflammation. These proteins, in turn, contribute to the local
inflammatory response, while further affecting electrophysiologic responses of pain and can
establish a continuous feedback.
The injured primary afferents terminate in the dorsal horn of the spinal cord, where they
communicate with spinal neurons via synaptic transmission. Many additional neurotransmitters (i.e.
glutamate, NMDA, substance P) modulate postsynaptic responses, with further transmission to
supraspinal sites via the ascending pathways [4]. Tissue damage (injury) generates an increased
neuronal excitability in the spinal cord [50]; associated with this sensitization is a decreased
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activation threshold, increased response magnitude, and increased recruitment of receptive fields
[41]. The continuous input from nociceptive afferents can drive the spinal circuits, leading to
central sensitization, and maintaining a chronic pain state [15]. These neuroplastic changes are
accompanied by other electrophysiological manifestations that cause neurons to fire with increased
frequency or even spontaneously [44]. In addition, spinal processing is further affected by
descending inhibitory and facilitory pathways that provide additional modulation of spinal
interneurons [40].
Persistent pain results from the sensitization of the central nervous system. While the exact
mechanism by which the spinal cord becomes sensitized or in a “hyperexcitable” state currently
remains somewhat unknown, many hypotheses have emerged.

Here only highlights of these

theories are provided as an overview. More extensive and detailed discussions can be found
elsewhere in the literature [6,16,18,50]. Simply, low threshold A afferents, which normally do not
serve to transmit a pain response, become recruited to transmit spontaneous and movement-induced
pain [16]. This central hyperexcitability is characterized by a “windup” response of repetitive C
fiber stimulation, expanding receptive field areas, and spinal neurons taking on properties of wide
dynamic range neurons [8]. Ultimately, A fibers stimulate postsynaptic neurons to transmit pain,
where these A fibers previously had no effect, all leading to central sensitization. Nociceptive
information is transmitted from the spinal cord to supraspinal sites, such as the thalamus and
cerebral cortex by ascending pathways.
Neuroimmunologic Responses in the CNS
While central sensitization contributes to nociceptive mechanisms of persistent pain in the
CNS, recent research has demonstrated the role of spinal neuroimmune responses as contributing to
persistent pain [14]. A collection of researchers has documented CNS immune changes associated
with persistent pain due to a host of painful syndromes, including radiculopathy, neuropathy,
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diabetes, and HIV, among others [10,32,37,42,43,47]. Work by DeLeo has focused on the role of
centrally produced proinflammatory cytokines, glial activation and leukocyte trafficking in a rodent
pain model of L5 lumbar radiculopathy [7,23,33,36,47], lending support for these immunologic
changes contributing to pain. From this body of work, a cascade of events in the CNS has been
proposed following injury [13,14]: cells (glia, neurons) become activated and can produce and
release cytokines which not only lead to their further activation, but also the release of pain
mediators [10,11,42]. Glial or neuronal proinflammatory cytokines can sensitize peripheral
nociceptive fields [25] and sensitize dorsal root ganglia [30].

Events that induce behavioral

hypersensitivity also activate immune cells both centrally and in the periphery, mediating chronic
pain [10,11,42]. Cytokines and growth factors have been strongly implicated in the generation of
pathological pain states throughout the nervous system; in particular, proinflammatory cytokines,
such as IL-1, IL-6 and TNF, are upregulated both locally and in the spinal cord in persistent pain
[10,51]. Immune activation with cytokine production may indirectly induce the expression of many
pain mediators such as glutamate, nitric oxide, and prostaglandins in the CNS, leading further to
spinal sensitization. In conjunction with this neuroimmune activation, neuroinflammation occurs in
which immune cells migrate from the periphery into the CNS in association with pain [13,14,33].
This infiltration may lead to further changes in the CNS and potentially to central sensitization.
Infiltrating immune cells contribute to neuronal activation and algesic mediator release, further
perpetuating the maintained excitability and sensitization in the CNS which leads to behavioral
sensitivity and pain. The spinal immune response of nociception has many facets, forming a
complicated cascade of events leading to pain.
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BIOMECHANICAL CONSIDERATIONS FOR PAIN MECHANISMS & NEUROIMMUNITY
Electrophysiologic and neuroimmune responses of the CNS likely work together to affect
pain for MSDs, with local biomechanics at the injury site modulating both such response cascades.
Low back pain is an ideal representative syndrome to use as an illustrative example for discussing
injury mechanisms and cellular response cascades of a chronic painful MSD in light of the previous
section on mechanisms. In this discussion, injury conditions are presented as examples of how
mechanical loading modulates nociception in low back pain, with particular emphasis on nerve root
injury (radiculopathy).
Many animal studies report altered electrophysiologic and cellular function for graded cauda
equina compression. Compression increases endoneurial pressure locally in the rat sciatic nerve and
DRG in proportion to mechanical loading [27,34]. In addition, edema patterns and intensity are
modulated by the nature of the mechanical insult [28,29,31,34]. Nerve root loading produces
changes in electrical impulse propagation and conduction velocity [9,22,35] and repetitive neuronal
firing in the dorsal horn of the spinal cord [22,52], which are all suggestive of sensitization leading
to pain. Similarly, it has been shown that tensile loading of facet capsule ligaments produces altered
neuronal firing indicative of injury and nociception and may be a causative mechanism of low back
pain [2,5]. While this collective body of work suggests a mechanism of spinal cord plasticity and
central sensitization for mechanical injuries, it is only inferential for understanding production and
maintenance of pain.
Work using imaging techniques has quantified nerve root tissue deformation in a rodent
model of painful lumbar radiculopathy [48,49] and examined this injury parameter in the context of
pain (behavioral hypersensitivity). Local injury mechanics was found to modulate pain behaviors; a
significant positive correlation exists in this pain model between behavioral sensitivity and the
amount of tissue injury [48]. Most simply, the greater nerve root compression at injury, the worse
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the clinical symptoms of behavioral sensitivity and pain. From this series of work, mechanical
thresholds for pain behaviors were defined based on the amount of nerve root compression [46].
These mechanical parameters defining painful injuries provide added utility for clinicians in
diagnosing painful injuries, directly linking the injury event to the likelihood of pain symptoms.
Moreover, in the future, it will hopefully provide insight into predicting clinical outcomes for this
class of injuries.
While defining the relationship between injury events and pain is necessary for
understanding the clinical context of these pathologies, defining the relationship between injury and
specific and relevant nociceptive responses is crucial for understanding the central mechanisms of
persistent pain in MSD. Using RNase Protection Assays to detect spinal mRNA of a panel of
cytokines (TNF , IL-1 / , IL-6, IL-10), a statistically significant correlation was found between
mRNA levels at postoperative day 7 and the degree of tissue deformation at injury [48]. This
suggests a modulatory effect of injury magnitude on one aspect of spinal nociception. Using
immunohistochemistry, spinal expression of the proinflammatory cytokine IL-1

has previously

been found to depend on nerve root compression intensity [23]; suggesting preservation of these
changes at both the message and protein levels for the spinal cytokines involved in chronic low back
pain responses. Consistent with the grading of behavioral responses and spinal cytokine expression
according to injury severity [23,48,49], spinal microglial activation is more intense for greater nerve
root deformation at injury [23,45]. Yet, astrocytic activation does not follow injury magnitude,
highlighting that biomechanics at injury in lumbar radiculopathy models may differentially
modulate some neuroimmune responses and not others (Figure 2).
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IMPLICATIONS FOR MSD: PAIN MECHANISMS & INJURY BIOMECHANICS
It is recognized that spinal injuries are by no means the only chronically painful MSDs. As
such, it should be noted that many of the theories described above may assist with developing a
more broad understanding in the context of other painful MSDs, such as carpal tunnel syndrome.
While magnitude, rate and duration of loading all modulate electrical signaling patterns (amplitude,
frequency) and local tissue changes (edema, pressure), and the neuroimmune cascade for painful
radiculopathy, their effects for other painful syndromes may be similar. Continued integration of
multidisciplinary approaches applied to a broader class of MSDs will help define nociceptive
responses in these disorders.
In the typical response of an acutely painful episode, the balance of injury, repair and healing
is achieved and the cascade of electrophysiologic and chemical events resolves following
inflammation and injury. However, for persistent pain, the local, spinal and even supraspinal,
responses are undoubtedly altered from that described above. Based on the discussion presented in
the previous sections regarding persistent pain, a comprehensive picture is emerging for nerve root
injury and CNS responses of nociception: spinal cytokine upregulation, microglial and astrocytic
activation, cellular adhesion molecule upregulation, and immune cell infiltration into the spinal cord
[13,14,36,39,42]. These aspects of neuroimmune activation induce the expression and release of
pain mediators (substance P, gluatmate, nitric oxide) and also lead to neuronal hypersensitivity. In
this context it is important to consider novel methods for preventing and treating painful injuries.
Clinical emphasis has largely been focused on local interventions at the injury site. However, the
previous discussion points to the spinal cord physiology as having equal, if not stronger,
contribution for maintenance of pain. Continued understanding of spinal and supraspinal
mechanisms and mediation of central sensitization can hopefully provide valuable contributions to
this understanding.
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IMPLICATIONS FOR MSD: APPLICATIONS & FUTURE RESEARCH
Emerging out of this discussion, it becomes clear that there are a number of areas of research
focuses which remain to be investigated for painful MSD (Table 1). From the broad coverage
presented above, it can be appreciated that many aspects of injury, physiology and cellular
mechanisms contribute to chronic pain in MSDs. In this context, then, it is possible to synthesize
these findings to discuss preventing these injuries and treating and managing them. As continued
biomechanical research is performed to determine conditions under which tissue injury occurs and
initiates physiologic responses, it becomes clear that findings can help guide preventive strategies to
protect some of these structures from undergoing kinematically and kinetically risky situations. In
addition, the cellular findings presented above highlight the need for defining the relationship of an
injury event, its physiologic responses, and their relationship to behavioral manifestations of pain
symptoms.
As the understanding of the mechanisms of persistent pain expands, increased research is
being focused on development of effective treatment modalities. A broad variety of approaches
exist for offering pain relief: joint blocks, TENS, manipulation, pharmacology, and many others
[13].

However, the exact mechanisms of injury often remain elusive, making it extremely

challenging to act at the structural site of injury for therapy. Pharmacologic treatment options offer
a promising approach for manipulating those aspects of the CNS response which contribute to
chronic nociception. For example, global immunosuppressants have been shown to ameliorate pain
behaviors in both neuropathic and radiculopathy rodent pain models [47]. Likewise, manipulation
of specific spinal cytokines to alter sensory processing and other select agents have been effective in
reducing allodynia in a variety of pain models [1,12,24,37,38,47]. Pharmacologic antagonists to and
inhibitors of particular proinflammatory cytokines and other algesic mediators (IL-1, TNF, COX-2)
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have shown effectiveness in animal pain models for attenuating both behavioral hypersensitivity and
elements of the CNS neuroimmune cascade [1,12,24,37,47]. Indeed, combinations of some of these
agents may have promise for effectiveness in reducing pain. As continued research identifies the
specific physiologic pathways (both electrophysiologic and immunologic) which are responsible for
chronic pain, it will become more feasible and even more tractable to target specific sites along
these pathways for selectively manipulating and modulating a persistent pain response.

With

continued integrative efforts, progress will be made in this area.
It is the hope that this review has provided a summary of current thinking in pain
mechanisms with a particular emphasis on how these mechanisms relate to injury and MSD.
Likewise, it was the intent to illuminate interesting new work within the stduy of pain, highlighting
the complications and intricacies of its nature. Lastly, through this presentation, areas of future
work have been indicated. It is only through continual efforts that meaningful advances will be
made in preventing and treating painful musculoskeletal disorders.
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TABLE 1. Suggested Future Work for Painful MSD:
Specific Areas of Investigation

1. Mechanisms for Anatomic Injury & Definition of Nociceptive Responses
• Identify anatomic structures at risk for injury
• Understand physiologic meaning of “injury” for these structures
• Identify injury factors which dominate pain
PREVENTION of painful injuries
DIAGNOSTIC tools & measures for prediction of management
2. Development of Effective Treatments & Managements
• Pain symptom attenuation
• Pharmacological treatments targeted at spinal changes
TREATMENT for chronic pain
MANAGEMENT strategies for pain
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FIGURE LEGENDS

Figure 1. This schematic illustrates physiologic mechanisms of pain following an inury in the
periphery. Nociceptive response are complicated and involve a host of changes both locally in
the central nervous system. While the schematic depicts a simple linear cascade (from left to
right)of events following injury which lead to pain perception, these events are quite dynamic in
nature and involve aspects of electrophysiology, immunology and an interplay between both.

Figure 2. There is a wide array of physiologic responses which occur following a mechanical
injury such as that resulting from MSD. hanges occur both at the site of injury and in the spinal
cord and CNS. However, the degree to which these alterations occur is variable and dependent
on both the nature of the injury and the type of response. For example, while it has been
determined that spinal cytokine mRNA follows patterns of tissue deformation, the spinal
astrocytic responses do not, suggesting a complicated and differential immune response for
mechanical loading of tissue. While a detailed understanding of the relationship between the
physiologic aspects of these responses is emerging, the role of biomechanics in pain onset and
maintenance remains uncharacterized.

It will be imperative to determine the relationship

between mechanical injury and the nociceptive physiologic responses detailed in this flow chart
(and others) for management of this class of injuries.
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